On February 28, 2023 RaySearch Laboratories reported that in the fourth quarter of 2022, order intake increased by 49 percent and net sales rose 40 percent. Operating profit amounted to SEK 21 M (-17) (Press release, RaySearch Medical, FEB 28, 2023, View Source [SID1234627910]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
FOURTH QUARTER (OCTOBER – DECEMBER 2022)
Order intake SEK 514.4 M (345.0)
Net sales SEK 264.4 M (188.6)
Operating profit SEK 20.7 M (-16.6))
Profit after tax SEK 14.1 M (-16.0)
Profit per share before/after dilution SEK 0.41 (-0.47)
Cash flow SEK 42.8 M (-20.1)
Order backlog SEK 1,940.1 M (1,362,9) at the end of the period
TWELVE MONTHS (JANUARY – DECEMBER 2022)
Order intake SEK 1,218.5 M (807.8)
Net sales SEK 843.6 M (641.7)
Operating profit SEK 42.7 M (-53.3)
Profit after tax SEK 23.8 M (-47.3)
Profit per share before/after dilution SEK 0.69 (-1.38)
Cash flow SEK 46.8 M (-71.7)
SIGNIFICANT EVENTS DURING THE FOURTH QUARTER
RaySearch received its largest order ever when Ion Beam Applications S.A. (IBA) placed an order of 17.3 MEUR for RayStation and RayCare for installation at nine proton centers in Spain.
University Hospitals Seidman Cancer Center/Case Western Reserve University in Cleveland, Ohio, in the United States, placed an order for RayStation.
CGN Medical Technologies placed an order for RayStation, which CGN sold together with IBA’s proton treatment system to Yangzhou Hospital in China.
Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) in the United States, placed an order for RayStation.